TrialThe lancet. HIV2020

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.

Esaú C João et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.